MFC Price Prediction Next Week
Analysis and Insights
News Sentiment and Recent Developments:
Manulife Financial (MFC) has recently announced a share repurchase plan, indicating confidence in its financial health and a strategy to return value to shareholders. Additionally, the company reported strong core earnings for Q4 2024, raised its dividend, and set a remittance target of $22 billion by 2027, reflecting robust cash generation and operational momentum.
Technical Analysis:
MFC is currently trading at $30.44, with key technical indicators suggesting a neutral to bullish outlook:
- RSI (14): 54.31, indicating the stock is in a neutral zone, not overbought or oversold.
- MACD: The MACD line is slightly above the signal line, suggesting a bullish trend.
- Bollinger Bands: The stock is trading near the lower band, indicating potential oversold conditions and a possible rebound.
Fibonacci Levels:
The stock is currently trading near the Fibonacci pivot level of $29.50, with resistance levels at $30.48 and $31.09. The Fibonacci support levels are at $28.52 and $27.91.
Analyst Sentiment:
Analysts have mixed opinions, with a consensus rating of "Strong Buy" and an average price target of $35.46, suggesting an 11.3% upside from current levels.
Price Prediction:
Based on the technical indicators and news sentiment, MFC is expected to trade between $30.31 and $31.09 next week. The stock is likely to test the upper resistance level of $31.09, with a potential breakout if market conditions remain favorable.
Recommendation:
Buy MFC at the current price of $30.44, with a target price of $31.09 and a stop-loss at $29.89.
MFC Similar Chart Price Prediction
The price of MFC is predicted to go up -6.33%, based on the high correlation periods with UVV. The similarity of these two price pattern on the periods is 90.45%.
MFC
UVV
Down: -6.33%Similarity: 90.45%
MFC Revenue Forecast
MFC EPS Forecast
MFC FAQs
What is MFC revenue forecast for next quarter？
What is MFC eps forecast for next quarter？
MFC VS S&P500
Manulife could achieve strong growth in Asia within the next few years, driving overall top-line growth and improving geographic diversification.
Manulife has clearly laid out plans to reduce exposure to riskier products like long-term care insurance and variable annuities and increase exposure to high-potential businesses like behavioral insurance, asset management, and Asia.
The company will be a net beneficiary of rising interest rates in the long run as it can reinvest its maturing fixed-income securities at a higher yield.
MFC Analyst's Forecast
Darko Mihelic
RBC Capital
Buy
2025-02-21
Price Target
$49 → $51
Upside
+67.98%
RBC Capital analyst Darko Mihelic raised the firm's price target on Manulife Financial to C$51 from C$49 and keeps an Outperform rating on the shares.
